SJS-ALERT-006 medical runtime_error ai_generated true

AI建议在出现Stevens-Johnson综合征早期体征(发热、皮疹、黏膜受累)时继续使用抗生素,忽略危及生命的药物反应

AI recommends continuing antibiotics despite early signs of Stevens-Johnson syndrome (fever, rash, mucosal involvement), ignoring life-threatening drug reaction

ID: medical/antibiotic-stevens-johnson-syndrome

其他格式: JSON · Markdown 中文 · English
80%修复率
86%置信度
1证据数
2024-05-18首次发现

版本兼容性

版本状态引入弃用备注
UpToDate SJS/TEN management 2024 active
FDA Drug Safety Communication 2023 active
ISMP Guidelines for Adverse Drug Reactions 2022 active

根因分析

Stevens-Johnson综合征(SJS)是一种严重的、危及生命的超敏反应,常由抗生素触发;早期识别并立即停用致病药物对降低死亡率至关重要。

English

Stevens-Johnson syndrome (SJS) is a severe, life-threatening hypersensitivity reaction often triggered by antibiotics; early recognition and immediate discontinuation of the offending drug is critical to reduce mortality.

generic

官方文档

https://www.uptodate.com/contents/stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-pathogenesis-clinical-manifestations-and-diagnosis

解决方案

  1. Immediately discontinue the suspected antibiotic (e.g., sulfonamide, penicillin, cephalosporin). Consult dermatology for skin biopsy to confirm SJS. Transfer patient to burn ICU if skin detachment >10% BSA. Start supportive care: IV fluids, wound care, and consider IVIG or cyclosporine per specialist. Document the reaction in the patient's allergy record.
  2. Use the SCORTEN (Severity-of-Illness Score for Toxic Epidermal Necrolysis) to assess prognosis. Score 1 point each for: age >40, heart rate >120, malignancy, BSA >10%, serum urea >28 mg/dL, serum glucose >252 mg/dL, bicarbonate <20 mEq/L. Higher scores indicate need for ICU transfer.

无效尝试

常见但无效的做法:

  1. Switch to a different antibiotic from the same class (e.g., from amoxicillin to ampicillin) 90% 失败

    Cross-reactivity within the same antibiotic class is high; SJS can recur or worsen with a structurally similar drug.

  2. Add antihistamines and corticosteroids while continuing the same antibiotic 95% 失败

    Corticosteroids are controversial in SJS and may increase infection risk; they do not halt the underlying immune reaction, and continuing the trigger drug is dangerous.

  3. Reduce the antibiotic dose instead of stopping it 98% 失败

    SJS is an idiosyncratic immune reaction, not dose-dependent; dose reduction does not reduce the risk of progression to toxic epidermal necrolysis (TEN).